BrightSpring Health Services (NASDAQ:BTSG) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Key Points

• BrightSpring Health Services reported an earnings per share (EPS) of $0.30, exceeding analysts' expectations of $0.27 by $0.03.
• The company's stock rose by 2.5% to a price of $30.47, with a market capitalization of $5.40 billion.
• Wall Street analysts maintain a positive outlook, with an average target price of $32.13 and a majority rating the stock as a "Buy."

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) announced its earnings results on Monday. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.03, Zacks reports. BrightSpring Health Services had a return on equity of 9.29% and a net margin of 0.55%. BrightSpring Health Services updated its Q3 2025 guidance to 0.300-0.300 EPS and its FY 2025 guidance to EPS.

BrightSpring Health Services Stock Up 2.5%

Shares of BTSG traded up $0.74 during mid-day trading on Monday, hitting $30.47. The company's stock had a trading volume of 2,970,210 shares, compared to its average volume of 2,438,329. The firm has a market capitalization of $5.40 billion, a price-to-earnings ratio of 98.29, a PEG ratio of 0.49 and a beta of 2.40. The company's 50-day moving average is $26.25 and its 200-day moving average is $22.72. The company has a current ratio of 1.76, a quick ratio of 1.34 and a debt-to-equity ratio of 1.43. BrightSpring Health Services has a 52-week low of $14.73 and a 52-week high of $31.95.

Hedge Funds Weigh In On BrightSpring Health Services

A number of large investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC acquired a new stake in shares of BrightSpring Health Services in the 2nd quarter worth $43,000. Sandia Investment Management LP purchased a new stake in BrightSpring Health Services during the 2nd quarter worth approximately $118,000. Jump Financial LLC acquired a new position in BrightSpring Health Services during the 2nd quarter valued at approximately $257,000. AQR Capital Management LLC purchased a new position in shares of BrightSpring Health Services in the first quarter worth $276,000. Finally, Brevan Howard Capital Management LP purchased a new stake in shares of BrightSpring Health Services during the second quarter valued at $295,000.

Wall Street Analysts Forecast Growth

BTSG has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft set a $30.00 price objective on shares of BrightSpring Health Services and gave the stock a "buy" rating in a research note on Monday, September 8th. Wall Street Zen cut shares of BrightSpring Health Services from a "strong-buy" rating to a "buy" rating in a research note on Saturday, July 26th. Morgan Stanley upped their price target on shares of BrightSpring Health Services from $25.00 to $32.00 and gave the company an "overweight" rating in a report on Tuesday, October 14th. TD Cowen started coverage on shares of BrightSpring Health Services in a research note on Monday, June 23rd. They issued a "buy" rating and a $37.00 price objective for the company. Finally, Wells Fargo & Company upped their target price on BrightSpring Health Services from $27.00 to $33.00 and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Nine analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $32.13.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.